• 9 aprile 2021 - UNA PUBBLICAZIONE SU "COVID -19 E CANCRO: UN ABBINAMENTO MORTALE" USCITA SULL' INTERNATIONAL JOURNAL OF CANCER DEL 9 APRILE 2021 (U. TIRELLI E S. CHIRUMBOLO)
    La mortalità per tumore, e così per certe malattie cardiovascolari come infarto e ictus, è incrementata per ritardi diagnostici e impossibilità a procedere alle terapie previste a causa del covid-19 (infezione concomitante di Sars-COV-2, mancanza di posti letto e di posti di terapia intensiva per infarti e ictus).
  • Genome wide DNA-profiling of HIV-related B-cell lymphomas.
    Br J Haematol. 2009 Oct 12. 
  • Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
    Lancet Oncol. 2009 Oct 12.
  • Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective.
    Ann Oncol. 2009 Aug;20(8):1445.
    Comment on: Ann Oncol. 2009 Mar;20(3):403-12.
  • High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long term results of the GICAT study with analysis of prognostic factors.
    Blood. 2009 May 18.
  • Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.
    Hum Pathol. 2009 May 6.
  • Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    J Med Virol. 2009 May;81(5):888-96.
  • Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas
    Br J Haematol. 2009 Feb 12.
  • Cancer in the elderly: The caregivers' perception of senior patients' informational needs.
    Arch Gerontol Geriatr. 2008 Dec 11.
  • HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
    AIDS. 2008 Oct 18;22(16):2143-53.
  • Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.
    Br J Cancer. 2008 Sep 9.
  • FOSFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients.
    J Chemother. 2008 Aug;20(4):503-8.
  • Cancer survivorship: a challenge for the European oncologists.
    Ann Oncol. 2008 Jun 4
  • Clinical management of long-term cancer survivors.
    J Clin Oncol. 2008 Jan 1;26(1):161-2
  • MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients.
    Int J Biol Markers. 2007 Oct-Dec;22(4):307-11.
  • Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study.
    Lung Cancer    . 2007 Nov 16
  • The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma.
    Int J Cancer. 2007 Dec 4
  • Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    N Engl J Med. 2007 Nov 8;357(19):1916-27
  • Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
    Clin Exp Immunol. 2007 Oct 11
  • Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
    Lung Cancer. 2006 Oct 23
  • Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.
    Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1168-77
  • Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    J Clin Oncol. 2006 Jul 1;24(19):3128-35
  • Treatment of elderly cancer patients: a planet in evolution.
    J Am Geriatr Soc. 2006 Feb;54(2):372-3
  • Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
    J Clin Oncol. 2006 Feb 1;24(4):681-7
  • AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.
    Blood. 2006 May 15;107(10):3832-40
  • Keynote comment: reimbursement for molecularly targeted anticancer agents.
    Lancet Oncol. 2006 Jan;7(1):2-3.
  • Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
    Ann Oncol. 2006 Mar;17(3):533.
  • Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
    Clin Lymphoma Myeloma. 2005 Sep;6(2):122-30.
  • Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
    J Clin Oncol. 2005 Oct 1;23(28):6865-72.
  • Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.
    Lung Cancer. 2005 Sep;49(3):417-8.
  • Cancer and aging: are there any differences in the information needs of elderly and younger patients? Results from an Italian observational study.
    Ann Oncol. 2005 Dec;16(12):1982-3.
  • Cancer Prevention and Early Diagnosis in HIV-Positive Individuals.
    J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):628-9.
  • Treatment of head and neck cancer in elderly patients: state of the art and guidelines.
    Crit Rev Oncol Hematol. 2005 Jan;53(1):71-80
  • Rituximab plus infusional cyclophosphamide, doxorubicin and etoposide (R-CDE) in HIV-associated non-Hodgkin's lymphoma: pooled results from three phase II trials.
    Blood. 2005 Mar 1;105(5):1891-7.
  • Fatigue in cancer patients receiving chemotherapy: analysis of published studies. 
    Ann Oncol. 2004 Oct;15(10):1576
  • Rituximab-CHOP or 2 weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
    Ann Oncol. 2004 Aug;15(8):1298
  • Improving information to Italian cancer patients: results of a randomized study.
    Ann Oncol. 2004 May;15(5):721-5.
  •  Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Cancer. 2003 Dec 1;98(11):2440-6.
  • High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
    J Clin Oncol. 2003 Dec 1;21(23):4423-7.
  • Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single institution study.
    J Clin Oncol. 2003 Nov 1;21(21):3948-54.
  • AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the  HAART era - the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals.
    J Clin Oncol. 2003 Aug 1;21(15):2876-82.
  • Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    N Engl J Med. 2003 Jun 12;348(24):2396-406.
  • Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan.
    J Clin Oncol. 2003 Feb 15;21(4):754
  • Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type.
    Cancer Immunol Immunother. 2003 Jan;52(1):28-32.
  • The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Sindrome Study Group. 
    Ann Intern Med. 1994 Dec 15;121(12):953-9.
  • Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC Study. 
  • A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute.
    Crit Rev Oncol Hematol. 2001 Feb;37(2):153-8. 
  • Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
    Cancer. 2001 Jan 1;91(1):155-63.
  • Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
    AIDS. 2000 Jul 7;14(10):1457-8.
  • Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy
    AIDS. 2000 Aug 18;14(12):1675-88
  • Immunological abnormalities in patients with chronic fatigue syndrome.
    Scand J Immunol. 1994 Dec;40(6):601-8. 
  • Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.
    Am J Med. 1998 Sep 28;105(3A):54S-58S. 
  • Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
  • Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
    J Clin Oncol. 1995 Jul;13(7):1758-67. 
  • Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
    J Clin Oncol. 1996 Aug;14(8):2217-23.
  • Invasive cervical cancer after treatment for cervical intraepithelial neoplasia.
    Lancet. 1997 Jun 28;349(9069):1909-10. 
  • Lung carcinoma in 36 patients with human immunodeficiency virus infection.
    Cancer. 2000 Feb 1;88(3):563-9.
  • Debate on Di Bella therapy.
    Lancet. 1999 Jul 10;354(9173):159.
  • Lung cancer in the elderly.
    Cancer Treat Rev. 1994 Oct;20(4):315-29.
  • Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
  • Cancer. 1995 Aug 1;76(3):535-6.
    Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective.
  • J Clin Oncol. 1988 Nov;6(11):1708-13.
  • Non Hodgkin's lymphoma in the elderly.
    Tumori. 2002 Jan-Feb;88(1 Suppl 1):S17-9.
  • A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.
    J Clin Oncol. 1992 Feb;10(2):228-36.
  • EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate-and high-grade lymphoma.
    Ann Oncol. 1994;5 Suppl 2:85-9.
  • CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
    J Clin Oncol. 1998 Jan;16(1):27-34.
  • Cancer in the elderly: why so badly treated?
    Lancet. 1990 Apr 28;335(8696):1020-2.
  • Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma.
    Clin Infect Dis. 2010 Jun 15;50(12):1672-9.
  • .HIV-Infected Patients and Liver Transplantation: Who, When and Why.
    Curr HIV Res. 2011 Feb 15.
  • Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat Hard.
    Oncologist. 2011;16(9):1258-69.
  • Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC).
    Arch Gerontol Geriatr. 2011 Sep 19.
  • Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
    Eur Rev Med Pharmacol Sci. 2011 Nov;15(11):1355-6.
  • 240. Two types of fatigue in cancer patients.
    BJ Cancer. 2012 Jan 17;106(2):424.
  • Oncologic drug shortages also in Italy.  
    Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):138-9.
  • Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma.
     Oncologist. 2012 May 18.